Antiobesity and Antidiabetic Actions of a New Potent Disaccharidase Inhibitor in Genetically Obese-Diabetic Mice, KKAy

Journal of Nutritional Science and Vitaminology

Volumn 38, Issue 1, 1992, Pages 27-37

  Odaka, Hiroyuki ^a   Shino, Akio ^a   Ikeda, Hitoshi ^a   Matsuo, Takao ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; ENZYME INHIBITOR; HEMOGLOBIN; SUCROSE; VOGLIBOSE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; DIABETES MELLITUS; DRUG STRUCTURE; ENZYME INHIBITION; FOOD INTAKE; HYPERGLYCEMIA; HYPERINSULINEMIA; MOUSE; NONHUMAN; OBESITY;

ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; CYCLOHEXANOLS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; INTESTINE, SMALL; KIDNEY; LIVER; MICE; MICE, INBRED STRAINS; OBESITY; SUCRASE;

ANIMALIA;

EID: 0026581055     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.38.27     Document Type: Article

References (22)

1. Puls, W., and Keup, U. (1974): Influence of a-amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man. Diabetologia, 9,97-101.
2. Puls, W., Keup, U., Krause, H. P., Thomas, G., and Hoffmeister, F. (1977): Glucosidase inhibitor. A new approach to the treatment of diabetes, obesity, and hyper-lipoproteinaemia. Naturwissenschaften, 64, 536-537.
3. Puls, W., Keup, U., Krause, H. P., Muller, L., Schmidt, D. D., Thomas, G., and Tsuscheit, E. (1980): Pharmacology of glucosidase inhibition. Front. Horm. Res., 7, 235-247.
4. Caspary, W. F., Lembcke, B., and Creutzfelt, W. (1982): Inhibition of human intestinal a-glucosidehydrolase activity by acarbose and clinical consequences, in First International Symposium on Acarbose, ed. by Creutzfeldt, W., International Congress Series 594, Excerpta Medica, Amsterdam-Oxford-Princeton, pp. 27-37.
5. Aubell, R., Boehme, K., and Berchtold, P. (1983): Blood glucose concentrations and glucosuria during and after one year of acarbose therapy. Arzneim.-Forsch. (Drug Res.), 33, 1314-1318.
6. Reaven, G. M., Lardinois, C. K., Greenfield, M. S., Schwartz, H. C. and Vreman, H. J. (1990): Effect of acarbose on carbohydrate and lipid metabolism in patients poorly controlled by sulfonylureas. Diabetes Care, 13 Sup. 3, 32-36.
7. Rybka, J., Gregorova, A., Zmydlena, A., and Jaron, P. (1990): Clinical study of acarbose. Drug Invest., 2, 264-267.
8. Horii, S., Fukase, H., Matsuo, T., Kameda, Y., Asano, N., and Masui, K. (1987): Synthesis and a-D-glucosidase inhibitory activity of iV-substituted valiolamine derivatives as potent oral antidiabetic agents. J. Med. Chem., 29, 1038-1046.
9. Odaka, H., Miki, N., Ikeda, H., and Matsuo, T. (1991): Effect of a potent disaccharidase inhibitor, AO-128, on postprandial hyperglycemia in rats. J. Jpn. Soc. Nutr. Food Sci., 45, 27-31.
10. Lwatsuka, H., Shino, A., and Suzuoki, Z. (1970): General survey of diabetic features of yellow KK mice. Endocrinol. Jpn., 17, 23-35.
11. Matsuo, T., Shimakawa, K., Ikeda, H., and Suzuoki, Z. (1984): Relation of body energetic status to dietary self-selection in Sprague-Dawley rats. J. Nutr. Sci. Vit-aminol., 30, 255-264.
12. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
13. Hales, C. N., and Randle, P. J. (1963): Immunoassay of insulin with insulin antibody precipitate. Biochem. J., 88, 137-146.
14. Ikeda, H., Nishikawa, K., and Matsuo, T. (1980): Feeding responses of Zucker fatty rat to 2-deoxy-D-glucose, norepinephrine, and insulin. Am. J. Physiol., 239, E379-E384.
15. Semenza, G. (1968): Intestinal oligosaccharidases and disaccharidases. in Handbook of Physiology, ed. by Code, C. F., Alimentary Canal Sect. 6, Vol. V, Am. Physiol. Soc., Washington, D.C., pp. 2543-2566.
16. Lee, S. M., Bustamante, S. A., and Koldovsky, O. (1983): The effect of alphaglucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice. Metabolism, 32, 793-799.
17. Bray, G. A., and York, D. A. (1971): Genetically transmitted obesity in rodents. Physiol. Rev., 51, 598-646.
18. Ikeda, H., Shino, A., Matsuo, T., Iwatsuka, H., and Suzuoki, Z. (1981): A new genetically obese-diabetic rat (Wistar fatty). Diabetes, 30, 1045-1050.
19. Iwatsuka, H., Taketomi, S., Matsuo, T., and Suzuoki, Z. (1974): Congenitally impaired hormone sensitivity of the adipose tissue of spontaneously diabetic mice, KK. Validity of thrifty genotype in KK mice. Diabetologia, 10, 611-616.
20. Fujita, T., Sugiyama, Y., Taketomi, S., Sohda, T., Kawamatsu, Y., Iwatsuka, H., and Suzuoki, Z. (1983): Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(l-methyl-cyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a new anti-diabetic agent. Diabetes, 32, 804-810.
21. Ikeda, H., Taketomi, S., Sugiyama, Y., Sohda, T., Meguro, K., and Fujita, T. (1990): Effect of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneium.-Forsch. (Drug Res.), 40, 156-162.
22. Taketomi, S., Tsuda, M., Matsuo, T., Iwatsuka, H., and Suzuoki, Z. (1973): Alteration of hepatic enzyme activities in KK and yellow KK mice with various diabetes states. Horm. Metab. Res., 5, 333-339.